MP77-11 IMPACT OF POSITRON EMISSION TOMOGRAPHY WITH 18 F-FLUCICLOVINE ON MANAGEMENT OF PATIENTS WITH SUSPECTED RECURRENCE OF PROSTATE CANCER: RESULTS FROM THE LOCATE TRIAL
نویسندگان
چکیده
منابع مشابه
Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography
Prostate cancer remains a major public health problem worldwide. Imaging plays an important role in the assessment of disease at all its clinical phases, including staging, restaging after definitive therapy, evaluation of therapy response, and prognostication. Positron emission tomography with a number of biologically targeted radiotracers has been demonstrated to have potential diagnostic and...
متن کاملDiagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial
Objective(s): The study objective was to assess the diagnostic performance of positron emission tomography (PET) for gliomas using the novel tracer 18F-fluciclovine (anti-[18F]FACBC) and to evaluate the safety of this tracer in patients with clinically suspected gliomas.Methods: Anti-[18F]FACBC was administered to 40 patients with clinically suspected high- or low-grade gliomas, followed by PET...
متن کاملتاثیر برنامه خودمدیریتی بر افسردگی، اضطراب و استرس بیماران سکته قلبی the effect of self management program on depression anxiety and stress of patients with myocardial infraction
چکیده : هدف :.این پژوهش با هدف تعیین تاثیر برنامه خودمدیریتی بر افسردگی، اضطراب و استرس بیماران سکته قلبی ا نجام شد. روش مطالعه : این پژوهش یک مطالعه تجربی دو گروهه ، قبل و بعد است که در سال 1389 در بیمارستان امام رضا (ع) کرمانشاه بر روی 60 مددجوی مبتلا به بیماری سکته قلبی ا نجام شد . نمونه ها به روش در دسترس جمع آوری و به روش بلوکهای تصادفی در دو گروه شاهد و آزمون تخصیص داده شدند . به مدت یک...
15 صفحه اولImpact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
PURPOSE Under Medicare's Coverage with Evidence Development policy, positron emission tomography (PET)/computed tomography (CT) and PET became covered services for previously noncovered cancer indications if prospective registry data were collected. The National Oncologic PET Registry (NOPR) was developed to meet these coverage requirements and to assess how PET affects care decisions. METHOD...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Urology
سال: 2018
ISSN: 0022-5347,1527-3792
DOI: 10.1016/j.juro.2018.02.2599